Trump signs order to expedite review of psychedelic drugs, including ibogaine to relax restrictions: ‘Going to have….’

What Happened

US President Donald Trump issued an executive order Saturday to expedite federal review of psychedelic substances, including Ibogaine, currently classified as high-risk illegal drugs. The administration aims to relax restrictions and promote research into potential medical applications for severe depression, PTSD, and opioid addiction. Combat veterans and conservative lawmakers support the move despite safety concerns.

Key Entities

AI Tools